In a new and disturbing twist on the obesity epidemic, some overweight teenagers have severe liver damage caused by too much body fat, and a handful have needed liver transplants
Both aggressive and hard to treat, liver cancer kills more than 650,000 a year worldwide. The American Cancer Society pegs the overall survival rate at less than 10%. Enter Aura Biosciences, a student startup that has developed an ingenious new means of delivering cancer-killing drugs to liver (and other) tumors.
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
Stocks slipped Monday as falling oil prices and a rash of corporate deals failed to rally investors concerned about reports on housing and testimony from Federal Reserve Chairman Ben Bernanke due later this week.
Stocks tumbled Monday afternoon, as a rash of corporate deals and a big selloff in oil prices failed to inspire investors ahead of key reports on housing and retail and testimony from Fed chief Ben Bernanke - all due later this week.
BACK WHEN HE WAS A GRAD STUDENT IN 1977, Paul Ewald came down with an intestinal bug. He'd been doing research at the University of Washington at Seattle on the social behavior of sparrows. But the...
Poor countries have cancer rates much closer to those of rich nations, reversing a long-held belief among medical researchers, a study released Thursday reports.
Blue-Chip Investors are rallying behind tiny Eximias Pharmaceutical Corp., which has spent four years developing a new chemotherapy drug for liver cancer (see "The Miracle Hunter," in February's FS...
For Ernest Lynton, the diagnosis was a death sentence. He had cancer of the pancreas, a disease so lethal that he would be lucky to live six months. Surgery had failed--the tumor was too large--and...
In a new and disturbing twist on the obesity epidemic, some overweight teenagers have severe liver damage caused by too much body fat, and a handful have needed liver transplants
Both aggressive and hard to treat, liver cancer kills more than 650,000 a year worldwide. The American Cancer Society pegs the overall survival rate at less than 10%. Enter Aura Biosciences, a student startup that has developed an ingenious new means of delivering cancer-killing drugs to liver (and other) tumors.
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
Stocks slipped Monday as falling oil prices and a rash of corporate deals failed to rally investors concerned about reports on housing and testimony from Federal Reserve Chairman Ben Bernanke due later this week.
Stocks tumbled Monday afternoon, as a rash of corporate deals and a big selloff in oil prices failed to inspire investors ahead of key reports on housing and retail and testimony from Fed chief Ben Bernanke - all due later this week.
BACK WHEN HE WAS A GRAD STUDENT IN 1977, Paul Ewald came down with an intestinal bug. He'd been doing research at the University of Washington at Seattle on the social behavior of sparrows. But the...
Poor countries have cancer rates much closer to those of rich nations, reversing a long-held belief among medical researchers, a study released Thursday reports.
Blue-Chip Investors are rallying behind tiny Eximias Pharmaceutical Corp., which has spent four years developing a new chemotherapy drug for liver cancer (see "The Miracle Hunter," in February's FS...
For Ernest Lynton, the diagnosis was a death sentence. He had cancer of the pancreas, a disease so lethal that he would be lucky to live six months. Surgery had failed--the tumor was too large--and...
METHYLENE CHLORIDE IS used in a slew of industrial processes, from making handlebar grips and hair spray to coating pills and taking the caffeine out of coffee beans. It strips paint without damagi...
The page you requested cannot be found. The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Please try the following:
• If you typed the page address in the Address bar, make sure that it is spelled correctly.
• Open the edition.cnn.com home page and look for links to the information you want.
• Use the navigation bar above to find the link you are looking for.
• Click the Back button to try another link.
• Enter a term in the search form below to look for information on CNN sites or the Internet.
